Early studies reported TOX to be a tumor cell-specific marker of CTCLs including early MF based on immunohistochemical findings that TOX was expressed in tumor cells of CTCLs but hardly in inflammatory infiltrates of BIDs [33,34]. Here, TOX is linked to neoplasm.